Gornitzky & Co.’s client, Moderna develops COVID-19 vaccine
As the world has waited for news of a breakthrough in the fight against Coronavirus, Moderna, which has developed a vaccine against COVID-19, has signed an agreement with the Israeli government for the supply of COVID-19 vaccines.
Data from Moderna states that its vaccine shows almost 95% protection, with Israeli chief medical officer of Moderna telling Ynet Israel would receive its vaccine before June 2021. “We don’t yet have a precise timetable. It will be in the first half of 2021. But when exactly, in which months, we can’t yet [say],” Dr. Tal Zacks said.
Gornitzky & Co. has advised on this landmark transaction. Firm Chairman Pinhas Rubin, and partners Chaim Friedland, Yoni Raff, Assaf Harel and Carolyn Zeimer Vigodny, Yehonatan Shiman alongside Josh Cohn had the privilege to act as Israeli counsel.
This transaction is one of many transactions that have been handled by Gornitzky in the healthcare and biomed sector. In the past year we are seeing a growth in the activity in this sector, among others, in light of COVID-19.
For further coverage in the Wall Street Journal, read here.
